title: The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.
abstract: The electrophysiological correlates of parkinsonism in the basal ganglia have been well studied in patients with Parkinson's disease and animal models. Separately, striatal dopaminergic cell transplantation has shown promise in ameliorating parkinsonian motor symptoms. However, the effect of dopaminergic grafts on basal ganglia electrophysiology has not thoroughly been investigated. In this study, we transplanted murine foetal ventral mesencephalic cells into rats rendered hemiparkinsonian by 6-hydroxydopamine injection. Three months after transplantation, extracellular and local field potential recordings were taken under urethane anaesthesia from the substantia nigra pars reticulata and subthalamic nucleus along with cortical electroencephalograms and were compared to recordings from normal and hemiparkinsonian controls. Recordings from cortical slow-wave activity and global activation states were analysed separately. Rats with histologically confirmed xenografts showed behavioural improvement measured by counting apomorphine-induced rotations and with the extended body axis test. Firing rates in both nuclei were not significantly different between control and grafted groups. However, burst firing patterns in both nuclei in the slow-wave activity state were significantly reduced (P < 0.05) in rats with large surviving grafts, compared to hemiparkinsonian controls. The neuronal firing entropies and oscillations in both nuclei were restored to normal levels in the large-graft group. Electroencephalogram spike-triggered averages also showed normalization in the slow-wave activity state (P < 0.05). These results suggest that local continuous dopaminergic stimulation exerts a normalizing effect on the downstream parkinsonian basal ganglia firing patterns. This novel finding is relevant to future preclinical and clinical investigations of cell transplantation and the development of next-generation therapies for Parkinson's disease that ameliorate pathophysiological neural activity and provide optimal recovery of function.
authors.affiliation: Department of Neurology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. timgilmour@psu.edu
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Gilmour
authors.forename: Brigitte
authors.initials: B
authors.lastname: Piallat
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Lieu
authors.forename: Kala
authors.initials: K
authors.lastname: Venkiteswaran
authors.forename: Renuka
authors.initials: R
authors.lastname: Ramachandra
authors.forename: Anand N
authors.initials: AN
authors.lastname: Rao
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Petticoffer
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Berk
authors.forename: Thyagarajan
authors.initials: T
authors.lastname: Subramanian
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D003342:Corpus Striatum / Q000378:metabolism / Q000503:physiopathology / Q000637:transplantation*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D009043:Motor Activity / Q000502:physiology; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D016627:Oxidopamine / Q000633:toxicity; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000378:metabolism / Q000503:physiopathology*; D020531:Subthalamic Nucleus / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D016627:Oxidopamine; D004298:Dopamine